We are live on
!
Find out more
FCMI
Foresite Capital Management II Portfolio holdings
AUM
$29.2M
1-Year Est. Return
44.84%
This Fund
S&P 500
This Quarter
Est. Return
-37.06%
1 Year Est. Return
+44.84%
3 Year Est. Return
-66.21%
5 Year Est. Return
-36.36%
10 Year Est. Return
–
AUM
$49.9M
AUM Growth
-$29.4M
(-37%)
Cap. Flow
$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
10x Genomics
TXG
$5.87B
| $49.9M | 100% |
1,753,528
| – | – |
|
Similar funds
AG
SAM
AC
QI
TAAM
NAM
MSKCC
BRC
Foresite Capital Management II's Q3 2022 Portfolio in Review
As of Q3 2022, Foresite Capital Management II held 1 position worth $49.9M, down 37% from $79.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 0%. Foresite Capital Management II opened no new positions and made no exits, leaving the 1-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Foresite Capital Management II's ten largest holdings make up 100% of its $49.9M portfolio in Q3 2022.
- Foresite Capital Management II opened 0 new positions and closed 0 in Q3 2022.
- Foresite Capital Management II's portfolio value fell 37% quarter-over-quarter to $49.9M.
Based on Foresite Capital Management II's 13F filing for Q3 2022, filed 14 Nov 2022.